INS and Insulin resistance: Using a specific JNK inhibitor (SP600125) that could block the kinase activity of JNK, we demonstrated a beneficial effect of JNK inhibition on the insulin signaling pathway and an indispensable role of its activation in FAF1-exacerbated insulin resistance.